Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

Ozempic and its counterparts, including Wegovy, Mounjaro and Zepbound, have surged in popularity as a means for weight loss, fueled by celebrity endorsements and slick pharmaceutical marketing.

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

Senators grilled Novo Nordisk CEO Lars Jrgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs, requesting explanations for why the U.S. faces a higher list ...

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

T he quest for effective and affordable weight loss solutions is a common challenge. While prescription medications like Ozempic have gained popularity, their high cost and potential side effects ...

A UK watchdog is urging women on GLP-1 weight-loss drugs like Ozempic and Mounjaro to use effective forms of birth control after receiving more than 40 pregnancy-related reports linked to the ...

Containers of Ozempic and Wegovy medications are seen at Children's Hospital in Aurora, Colo.. Some Minnesota school district leaders say the high cost of covering popular GLP-1 weight loss drugs ...

The United Kingdom's health regulator is investigating weight loss jabs like Ozempic and Mounjaro after linking it to hundreds of severe illnesses and deaths. As The Independent reports, the UK ...

Ozempic Patent Expires In Canada After Novo Nordisk Fails To Pay $450 Fee: 'It's The Second-Largest Semaglutide Market In The World,' Says Sandoz CEO Richard Saynor (UPDATED) by Vishaal Sanjay Follow ...

Novo Nordisk said on Monday the European drugs regulator will allow a label update for its diabetes drug Ozempic to include a condition called peripheral artery disease.